Lindsay Tetreault1, Branko Kopjar2, Pierre Côté3, Paul Arnold4, Michael G Fehlings1. 1. Toronto Western Hospital, University of Toronto, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada. E-mail address for L. Tetreault: Lindsay.tetreault@uhn.ca. E-mail address for M.G. Fehlings: Michael.Fehlings@uhn.on.ca. 2. University of Washington, 4333 Brooklyn Avenue N.E., Suite 1400/#315, Box 359455, Seattle, WA 98185. E-mail address: brankok@u.washington.edu. 3. Centre for the Study of Disability Prevention and Rehabilitation, University of Ontario Institute of Technology-CMCC, 2000 Simcoe Street North, Oshawa, ON L1H 7K4, Canada. E-mail address: pierre.cote@uoit.ca. 4. Department of Neurosurgery, University of Kansas, 3901 Rainbow Boulevard, Kansas City, KS 66160. E-mail address: parnold@kumc.edu.
Abstract
BACKGROUND: Cervical spondylotic myelopathy (CSM) is a progressive spinal condition that is often managed surgically. Knowledge of important predictors of surgical outcome can provide decision support to surgeons and enable them to effectively manage their patients' expectations. The purpose of this study was to identify the most important clinical predictors of surgical outcome in patients with CSM using data from two multinational prospective studies. METHODS: A total of 757 patients treated surgically for CSM participated in either the CSM-North America or the CSM-International study. The model was designed to distinguish between patients who achieved a modified Japanese Orthopaedic Association (mJOA) score of ≥16 at the one-year follow-up and those who did not (mJOA < 16). A score of 16 was chosen as the cutoff as an mJOA of ≥16 translates to minimal impairment. Univariate analyses evaluated the relationship between outcome and various clinical predictors. Multivariate Poisson regression was used to create the final prediction rule and estimate relative risks. RESULTS: Based on univariate analyses, the probability of achieving a score of ≥16 decreased with the presence of certain symptoms, including gait dysfunction, the presence of certain signs such as lower limb spasticity, positive smoking status, higher comorbidity score, more severe preoperative myelopathy, and older age. The final model consisted of six significant and clinically relevant predictors: baseline severity score (relative risk [RR], 1.11; 95% confidence interval [CI], 1.07 to 1.15), impaired gait (RR, 0.76 [ref. = absence]; 95% CI, 0.66 to 0.88), age (RR, 0.91 per decade; 95% CI, 0.85 to 0.96), comorbidity score (RR, 0.93; 95% CI, 0.88 to 0.98), smoking status (RR, 0.78 [ref. = non-smoking]; 95% CI, 0.65 to 0.93), and duration of symptoms (RR, 0.95; 95% CI, 0.90 to 0.99). CONCLUSIONS: Patients were more likely to achieve a score of ≥16 (indicating minimal impairment) if they were younger, had milder preoperative myelopathy, did not smoke, had fewer and less severe comorbidities, did not present with impaired gait, and had shorter symptom duration.
BACKGROUND: Cervical spondylotic myelopathy (CSM) is a progressive spinal condition that is often managed surgically. Knowledge of important predictors of surgical outcome can provide decision support to surgeons and enable them to effectively manage their patients' expectations. The purpose of this study was to identify the most important clinical predictors of surgical outcome in patients with CSM using data from two multinational prospective studies. METHODS: A total of 757 patients treated surgically for CSM participated in either the CSM-North America or the CSM-International study. The model was designed to distinguish between patients who achieved a modified Japanese Orthopaedic Association (mJOA) score of ≥16 at the one-year follow-up and those who did not (mJOA < 16). A score of 16 was chosen as the cutoff as an mJOA of ≥16 translates to minimal impairment. Univariate analyses evaluated the relationship between outcome and various clinical predictors. Multivariate Poisson regression was used to create the final prediction rule and estimate relative risks. RESULTS: Based on univariate analyses, the probability of achieving a score of ≥16 decreased with the presence of certain symptoms, including gait dysfunction, the presence of certain signs such as lower limb spasticity, positive smoking status, higher comorbidity score, more severe preoperative myelopathy, and older age. The final model consisted of six significant and clinically relevant predictors: baseline severity score (relative risk [RR], 1.11; 95% confidence interval [CI], 1.07 to 1.15), impaired gait (RR, 0.76 [ref. = absence]; 95% CI, 0.66 to 0.88), age (RR, 0.91 per decade; 95% CI, 0.85 to 0.96), comorbidity score (RR, 0.93; 95% CI, 0.88 to 0.98), smoking status (RR, 0.78 [ref. = non-smoking]; 95% CI, 0.65 to 0.93), and duration of symptoms (RR, 0.95; 95% CI, 0.90 to 0.99). CONCLUSIONS:Patients were more likely to achieve a score of ≥16 (indicating minimal impairment) if they were younger, had milder preoperative myelopathy, did not smoke, had fewer and less severe comorbidities, did not present with impaired gait, and had shorter symptom duration.
Authors: Lee Wen-Shen; Maksim Lai Wern Sheng; William Yeo; Tan Seang Beng; Yue Wai Mun; Guo Chang Ming; Mohammad Mashfiqul Arafin Siddiqui Journal: Int J Spine Surg Date: 2020-12-29
Authors: Phillip Grisdela; Zorica Buser; Anthony D'Oro; Permsak Paholpak; John C Liu; Jeffrey C Wang Journal: Eur Spine J Date: 2017-05-09 Impact factor: 3.134
Authors: Pia M Vidal; Spyridon K Karadimas; Antigona Ulndreaj; Alex M Laliberte; Lindsay Tetreault; Stefania Forner; Jian Wang; Warren D Foltz; Michael G Fehlings Journal: JCI Insight Date: 2017-06-02
Authors: Ankur S Narain; Fady Y Hijji; Benjamin Khechen; Brittany E Haws; Dil V Patel; Daniel D Bohl; Kelly H Yom; Krishna T Kudaravalli; Kern Singh Journal: Int J Spine Surg Date: 2019-06-30
Authors: Peter G Passias; Samantha R Horn; Cheongeun Oh; Subaraman Ramchandran; Douglas C Burton; Virginie Lafage; Renaud Lafage; Gregory W Poorman; Leah Steinmetz; Frank A Segreto; Cole A Bortz; Justin S Smith; Christopher Ames; Christopher I Shaffrey; Han Jo Kim; Alexandra Soroceanu; Eric O Klineberg Journal: J Spine Surg Date: 2018-06